Use of gene expression signature technology to identify VVP-808, a novel insulin sensitiser with efficacy in vitro and in vivo

Walder, Ken; Molero, J; Konstantopoulos, Nicky; Segal, D; Foletta, Victoria; Windmill, Kelly; Curran, J; Dyer, T; Shields, K; Jowett, Jeremy; Krippner, G; Blangero, J; Collier, Gregory

Use of gene expression signature technology to identify VVP-808, a novel insulin sensitiser with efficacy in vitro and in vivo

journal contribution

posted on 2008-01-01, 00:00 authored by Ken WalderKen Walder, J Molero, Nicky Konstantopoulos, D Segal, Victoria Foletta, Kelly WindmillKelly Windmill, J Curran, T Dyer, K Shields, Jeremy Jowett, G Krippner, J Blangero, Gregory Collier

Use of gene expression signature technology to identify VVP-808, a novel insulin sensitiser with efficacy in vitro and in vivo

History

Journal

Diabetologia : clinical and experimental diabetes and metabolism

Volume

51

Issue

Supplement 1

Publisher

Springer

Location

Berlin, Germany

ISSN

0012-186X

eISSN

1432-0428

Language

eng

Notes

This article is located on the 374th page in the attached link.

Publication classification

C2.1 Other contribution to refereed journal

Copyright notice

2008, Springer

Usage metrics

Keywords

Untagged

Use of gene expression signature technology to identify VVP-808, a novel insulin sensitiser with efficacy in vitro and in vivo

History

Journal

Volume

Issue

Publisher

Location

ISSN

eISSN

Language

Notes

Publication classification

Copyright notice

Usage metrics

Categories

Keywords

Licence

Exports